List view / Grid view
8 February 2017 | By Niamh Marriott, Digital Editor
NICE has today published draft guidance recommending the Intrabeam Radiotherapy System (Carl Zeiss UK) for people with early breast cancer...
7 February 2017 | By Niamh Marriott, Digital Editor
Nanobiotix, a late clinical-stage nanomedicine company, announced the appointment of Alain Dostie, a senior executive from the pharmaceutical industry, as its Chief Operating Officer. Mr Dostie will lead Nanobiotix’s operations, including development, manufacturing, market access and sales, for their lead product NBTXR3, which could obtain a CE Mark approval in…
7 February 2017 | By Metrohm Appllikon
When it comes to monitoring industrial manufacturing processes, NIRS offers a rapid and reliable supplement to conventional titration methods...
6 February 2017 | By Metrohm
The Mira M-3 is the new handheld Raman spectrometer from Metrohm. Barely larger than a smartphone, the Mira M-3 enables true single-handed operation...
3 February 2017 | By Niamh Marriott, Digital Editor
The US Food and Drug Administration (FDA) has authorised Abbott’s molecular test to detect Zika virus in whole blood (when collected alongside a patient-matched serum or plasma sample) for emergency use. This is the first molecular test made by a commercial manufacturer authorised to detect Zika in whole blood samples;…
3 February 2017 | By Niamh Marriott, Digital Editor
NICE has today published draft guidance which does not recommend Pfizer's breast cancer drug palbociclib for routine funding on the NHS...
2 February 2017 | By Niamh Marriott, Digital Editor
From today, UK patients with an incurable form of bladder cancer can access the new immunotherapy, atezolizumab, following a positive Scientific Opinion...
Linkam Scientific Instruments, announce the launch of the CMS196M for enhanced Cryo Correlative Microscopy with greatly improved work flow...
25 January 2017 | By marcus evans
This marcus evans forum will help delegates to structure the Alliance management internally as well as to offer an insight on the responsibilities and roles of the Alliance function...
25 January 2017 | By Wickham Laboratories
Wickham Laboratories Ltd is pleased to provide the results of our case study on the bioburden of the new polymer £5 note...
Russell Compact Sieve combined with high containment isolator provide innovative screening solution for pharmaceutical manufacturer.
23 January 2017 | By Niamh Marriott, Digital Editor
The application is supported by data from two Phase 3 studies, which evaluated 12 weeks of the fixed-dose combination in antiviral-experienced patients...
Ethypharm has signed a definitive agreement to acquire Martindale Pharma.
20 January 2017 | By Niamh Marriott, Digital Editor
The multiple sclerosis therapy alemtuzumab can trigger severe, unpredictable side effects...
19 January 2017 | By Niamh Marriott, Digital Editor
Panacea Pharmaceuticals have enrolled and dosed the first patient in the open-label, parallel designed, multi-centre Phase I clinical trial of PAN-301-1, for the treatment of persistent prostate cancer to assess safety and immunogenicity. Clinical sites for the PAN-301-1 trial are located in Alabama, California, Nebraska and South Carolina and the…
